Cancer Immunotherapy Using Microfluidic Systems
- سال انتشار: 1403
- محل انتشار: فصلنامه پزشکی شخصی، دوره: 9، شماره: 33
- کد COI اختصاصی: JR_PMJ-9-33_001
- زبان مقاله: انگلیسی
- تعداد مشاهده: 84
نویسندگان
Department of veterinary medicine, Islamic Azad University of Tabriz, Tabriz,Iran.
چکیده
Physicians are enthusiastic about using a novel approach known as cancer immunotherapy to address various forms of cancer. However, there are occasions when novel therapies that demonstrate efficacy in laboratory settings may not provide the same level of effectiveness when applied to actual patients. To address this issue, scientists are using miniature replicas known as microfluidic models. These models provide the examination of the interaction between cancer and immune cells in a manner that closely resembles the physiological conditions inside the human body. This review examines the role of microfluidic models in advancing the development of more effective cancer therapies. Let's begin by discussing the current state of affairs in cancer immunotherapy. Next, we explore the use of microfluidic models by scientists to gain insights into the mechanisms via which the immune system combats cancer and to evaluate the efficacy of novel therapeutic interventions. Additionally, we discuss the first measures used to demonstrate the efficacy of these models in predicting the effectiveness of therapies in human subjects. Lastly, we will discuss the advantages of using microfluidic models and the necessary steps to enhance their efficacy in the development of novel cancer therapies.کلیدواژه ها
Microfluidic models, Immunotherapy, Cancerاطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.